Nexpoint Asset Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Nexpoint Asset Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,613,419	Closed	-$35.8M	–	127
2023 Q1	$35.8M	Buy	3,613,419 +3,599,519	+25,896%	+$35.7M	3.88%	8
2022 Q4	$139K	Buy	+13,900	New	+$104K	0.01%	106

Nexpoint Asset Management's APEN Position: Q2 2023 in Review

Nexpoint Asset Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 3,613,419 shares — an estimated $35.8M sold.

Nexpoint Asset Management first reported a position in APEN in Q4 2022 and held it in 2 quarters. The position peaked at $35.8M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Nexpoint Asset Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Nexpoint Asset Management sold 3,613,419 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $35.8M.
Nexpoint Asset Management first reported a position in Apollo Endosurgery, Inc. in Q4 2022 and held it in 2 quarters.
Nexpoint Asset Management's Apollo Endosurgery, Inc. position peaked at $35.8M in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Nexpoint Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.